financetom
Business
financetom
/
Business
/
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
May 10, 2024 1:04 PM

03:32 PM EDT, 05/10/2024 (MT Newswires) -- Alpine Immune Sciences ( ALPN ) and Vertex Pharmaceuticals ( VRTX ) said Friday the waiting period under the Hart-Scott-Rodino antitrust act related to their merger deal expired Thursday.

Vertex has agreed to acquire Alpine for $4.9 billion in cash, or $65 a share.

Price: 64.94, Change: +0.12, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved